Cardiac computed tomography: from anatomy to function.
Computed tomography
Diagnosis
Ischaemic heart disease
Prognosis
Journal
European heart journal supplements : journal of the European Society of Cardiology
ISSN: 1520-765X
Titre abrégé: Eur Heart J Suppl
Pays: England
ID NLM: 100886647
Informations de publication
Date de publication:
May 2023
May 2023
Historique:
medline:
1
5
2023
pubmed:
1
5
2023
entrez:
1
5
2023
Statut:
epublish
Résumé
Ischaemic heart disease (IHD) is one of the world's leading causes of morbidity and mortality. Likewise, the diagnosis and risk stratification of patients with coronary artery disease (CAD) have always been based on the detection of the presence and extent of ischaemia by physical or pharmacological stress tests with or without the aid of imaging methods (e.g. exercise stress, test, stress echocardiography, single-photon emission computed tomography, or stress cardiac magnetic resonance). These methods show high performance to assess obstructive CAD, whilst they do not show accurate power to detect non-obstructive CAD. The introduction into clinical practice of coronary computed tomography angiography, the only non-invasive method capable of analyzing the coronary anatomy, allowed to add a crucial piece in the puzzle of the assessment of patients with suspected or chronic IHD. The current review evaluates the technical aspects and clinical experience of coronary computed tomography in the evaluation of atherosclerotic burden with a special focus about the new emerging application such as functional relevance of CAD with fractional flow reserve computed tomography (CT)-derived (FFRct), stress CT perfusion, and imaging inflammatory makers discussing the strength and weakness of each approach.
Identifiants
pubmed: 37125321
doi: 10.1093/eurheartjsupp/suad037
pii: suad037
pmc: PMC10132556
doi:
Types de publication
Journal Article
Langues
eng
Pagination
C49-C57Informations de copyright
© The Author(s) 2023. Published by Oxford University Press on behalf of the European Society of Cardiology.
Déclaration de conflit d'intérêts
Conflict of interest: None declared.
Références
J Am Coll Cardiol. 2014 Apr 1;63(12):1145-1155
pubmed: 24486266
Circulation. 2021 Sep 28;144(13):1024-1038
pubmed: 34496632
J Am Coll Cardiol. 2018 Jun 5;71(22):2511-2522
pubmed: 29852975
AJR Am J Roentgenol. 1976 Apr;126(4):786-91
pubmed: 179347
Eur Heart J. 2018 Nov 1;39(41):3689-3698
pubmed: 30312411
N Engl J Med. 2017 Sep 21;377(12):1119-1131
pubmed: 28845751
Sci Transl Med. 2017 Jul 12;9(398):
pubmed: 28701474
J Am Coll Cardiol. 2020 Nov 24;76(21):2421-2432
pubmed: 33213720
J Am Coll Cardiol. 2010 Mar 16;55(11):1110-7
pubmed: 20223365
Lancet. 2015 Jun 13;385(9985):2383-91
pubmed: 25788230
JACC Cardiovasc Imaging. 2018 Oct;11(10):1475-1484
pubmed: 29909109
Lancet. 2018 Sep 15;392(10151):929-939
pubmed: 30170852
JAMA Cardiol. 2018 Feb 1;3(2):144-152
pubmed: 29322167
J Am Coll Cardiol. 2011 Aug 16;58(8):849-60
pubmed: 21835321
J Am Coll Cardiol. 2018 Jun 19;71(24):2756-2769
pubmed: 29802016
Circulation. 1998 Feb 17;97(6):535-43
pubmed: 9494023
J Am Coll Cardiol. 2014 Aug 19;64(7):684-92
pubmed: 25125300
J Am Coll Cardiol. 2018 Jul 24;72(4):434-447
pubmed: 30025580
Am J Epidemiol. 2002 Nov 1;156(9):871-81
pubmed: 12397006
J Am Coll Cardiol. 2016 Aug 2;68(5):435-445
pubmed: 27470449
JACC Cardiovasc Imaging. 2019 Aug;12(8 Pt 1):1487-1497
pubmed: 30343073
Eur Heart J. 2020 Jan 14;41(3):407-477
pubmed: 31504439
J Cardiovasc Comput Tomogr. 2016 Jul-Aug;10(4):269-81
pubmed: 27318587
JAMA Cardiol. 2020 Dec 1;5(12):1338-1348
pubmed: 32822476
Eur Heart J Cardiovasc Imaging. 2022 Feb 22;23(3):299-314
pubmed: 35076061
J Am Coll Cardiol. 2021 Nov 16;78(20):1950-1953
pubmed: 34763771
Radiology. 1981 Aug;140(2):413-20
pubmed: 6973166
JACC Cardiovasc Interv. 2014 Feb;7(2):195-201
pubmed: 24440015